N

Neurocrine Biosciences

D
NBIX
USD
-2.675
(-2.1306%)
Market Closed
43,511.00
حجم التداول
5
الربح لكل سهم
-
العائد الربحي
37.011
P/E
12,407,456,595.88
حجم السوق
اليوم
-2.1306%
1 اسبوع
-0.955%
1 شهر
5.499%
6 اشهر
-11.166%
12 اشهر
9.319%
بداية السنة
-6.736%
كل الوقت
0%
avatar
sara abdelazim
عدد النقاط
112
عدد التوصيات
2

Title:
Neurocrine Biosciences

Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.
هل تحتاج مساعدة او لديك استفسار؟